{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:39:37Z","timestamp":1771306777986,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["PEst-C\/SAU\/LA0001\/2013-2014"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2013-2014"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["SFRH\/BD\/65130\/2009"],"award-info":[{"award-number":["SFRH\/BD\/65130\/2009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00280-016-3129-0","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T21:46:11Z","timestamp":1472852771000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box?"],"prefix":"10.1007","volume":"79","author":[{"given":"Mariana P. C.","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Jos\u00e9 B. A.","family":"Cust\u00f3dio","sequence":"additional","affiliation":[]},{"given":"Armanda E.","family":"Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"3129_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","volume":"50","author":"CM Niswender","year":"2010","unstructured":"Niswender CM, Conn PJ (2010) Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50:295\u2013322","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3129_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405\u2013496","journal-title":"Pharmacol Rev"},{"key":"3129_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1755-148X.2012.00983.x","volume":"25","author":"JL Teh","year":"2012","unstructured":"Teh JL, Chen S (2012) Glutamatergic signaling in cellular transformation. Pigment Cell Melanoma Res 25:331\u2013342","journal-title":"Pigment Cell Melanoma Res"},{"key":"3129_CR4","doi-asserted-by":"crossref","unstructured":"Yu LJ, Wall BA,Wangari-Talbot J, Chen S (2016) Metabotropic glutamate receptors in cancer. Neuropharmacology (in press)","DOI":"10.1016\/j.neuropharm.2016.02.011"},{"key":"3129_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"JN Kew","year":"2005","unstructured":"Kew JN, Kemp JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:4\u201329","journal-title":"Psychopharmacology"},{"key":"3129_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuropharm.2008.08.006","volume":"56","author":"D Lodge","year":"2009","unstructured":"Lodge D (2009) The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 56:6\u201321","journal-title":"Neuropharmacology"},{"key":"3129_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","volume":"11","author":"S Cull-Candy","year":"2001","unstructured":"Cull-Candy S, Brickley S, Farrant M (2001) NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11:327\u2013335","journal-title":"Curr Opin Neurobiol"},{"key":"3129_CR8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","volume":"97","author":"HS Chen","year":"2006","unstructured":"Chen HS, Lipton SA (2006) The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97:1611\u20131626","journal-title":"J Neurochem"},{"key":"3129_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/pr.57.2.7","volume":"57","author":"CL Palmer","year":"2005","unstructured":"Palmer CL, Cotton L, Henley JM (2005) The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev 57:253\u2013277","journal-title":"Pharmacol Rev"},{"key":"3129_CR10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tins.2007.01.006","volume":"30","author":"SJ Liu","year":"2007","unstructured":"Liu SJ, Zukin RS (2007) Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci 30:126\u2013134","journal-title":"Trends Neurosci"},{"key":"3129_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fnmol.2011.00033","volume":"4","author":"T Hideyama","year":"2011","unstructured":"Hideyama T, Kwak S (2011) When does ALS Start? ADAR2-GluA2 hypothesis for the etiology of sporadic ALS. Front Mol Neurosci 4:33","journal-title":"Front Mol Neurosci"},{"key":"3129_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2011.00042","volume":"4","author":"JH Weiss","year":"2011","unstructured":"Weiss JH (2011) Ca permeable AMPA channels in diseases of the nervous system. Front Mol Neurosci 4:42","journal-title":"Front Mol Neurosci"},{"key":"3129_CR13","first-page":"34","volume":"5","author":"A Wright","year":"2012","unstructured":"Wright A, Vissel B (2012) The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain. Front Mol Neurosci 5:34","journal-title":"Front Mol Neurosci"},{"key":"3129_CR14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1152\/physrev.2001.81.3.971","volume":"81","author":"J Lerma","year":"2001","unstructured":"Lerma J, Paternain AV, Rodr\u00edguez-Moreno A, L\u00f3pez-Garc\u00eda JC (2001) Molecular physiology of kainate receptors. Physiol Rev 81:971\u2013998","journal-title":"Physiol Rev"},{"key":"3129_CR15","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/ijc.24958","volume":"126","author":"CS Wu","year":"2010","unstructured":"Wu CS, Lu YJ, Li HP, Hsueh C, Lu CY, Leu YW, Liu HP, Lin KH, Hui-Ming Huang T, Chang YS (2010) Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer 126:2542\u20132552","journal-title":"Int J Cancer"},{"key":"3129_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/med.20084","volume":"27","author":"D Catarzi","year":"2007","unstructured":"Catarzi D, Colotta V, Varano F (2007) Competitive AMPA receptor antagonists. Med Res Rev 27:239\u2013278","journal-title":"Med Res Rev"},{"key":"3129_CR17","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1073\/pnas.121179198","volume":"98","author":"EA Cavalheiro","year":"2001","unstructured":"Cavalheiro EA, Olney JW (2001) Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci USA 98:5947\u20135948","journal-title":"Proc Natl Acad Sci USA"},{"key":"3129_CR18","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1523\/JNEUROSCI.19-14-05861.1999","volume":"19","author":"MS Perkinton","year":"1999","unstructured":"Perkinton MS, Sihra TS, Williams RJ (1999) Ca(2+)-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons. J Neurosci 19:5861\u20135874","journal-title":"J Neurosci"},{"key":"3129_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0024-3205(00)00632-9","volume":"67","author":"J Platenik","year":"2000","unstructured":"Platenik J, Kuramoto N, Yoneda Y (2000) Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci 67:335\u2013364","journal-title":"Life Sci"},{"key":"3129_CR20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1460-9568.2004.03223.x","volume":"19","author":"L Mao","year":"2004","unstructured":"Mao L, Tang Q, Samdani S, Liu Z, Wang JQ (2004) Regulation of MAPK\/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur J Neurosci 19:1207\u20131216","journal-title":"Eur J Neurosci"},{"key":"3129_CR21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.neuropharm.2012.04.033","volume":"63","author":"NM Fournier","year":"2012","unstructured":"Fournier NM, Lee B, Banasr M, Elsayed M, Duman RS (2012) Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK\/ERK- and PI3\u00a0K\/Akt-dependent signaling. Neuropharmacology 63:642\u2013652","journal-title":"Neuropharmacology"},{"key":"3129_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","volume":"283","author":"C Ikonomidou","year":"1999","unstructured":"Ikonomidou C, Bosch F, Miksa M, Bittigau P, V\u00f6ckler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70\u201374","journal-title":"Science"},{"key":"3129_CR23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.nbd.2004.03.013","volume":"16","author":"HH Hansen","year":"2004","unstructured":"Hansen HH, Briem T, Dzietko M, Sifringer M, Voss A, Rzeski W, Zdzisinska B, Thor F, Heumann R, Stepulak A, Bittigau P, Ikonomidou C (2004) Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 16:440\u2013453","journal-title":"Neurobiol Dis"},{"key":"3129_CR24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-4547(19961015)46:2<164::AID-JNR4>3.0.CO;2-F","volume":"46","author":"A Yoshioka","year":"1996","unstructured":"Yoshioka A, Ikegaki N, Williams M, Pleasure D (1996) Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J Neurosci Res 46:164\u2013178","journal-title":"J Neurosci Res"},{"key":"3129_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.0305-1846.2001.00314.x","volume":"27","author":"E Aronica","year":"2001","unstructured":"Aronica E, Yankaya B, Jansen GH, Leenstra S, van Veelen CW, Gorter JA, Troost D (2001) Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy. Neuropathol Appl Neurobiol 27:223\u2013237","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3129_CR26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","volume":"8","author":"S Ishiuchi","year":"2002","unstructured":"Ishiuchi S, Tsuzuki K, Yoshida Y, Yamada N, Hagimura N, Okado H, Miwa A, Kurihara H, Nakazato Y, Tamura M, Sasaki T, Ozawa S (2002) Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971\u2013978","journal-title":"Nat Med"},{"key":"3129_CR27","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1046\/j.1460-9568.2002.02403.x","volume":"16","author":"M Pizzi","year":"2002","unstructured":"Pizzi M, Boroni F, Bianchetti A, Moraitis C, Sarnico I, Benarese M, Goffi F, Valerio A, Spano P (2002) Expression of functional NR1\/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur J Neurosci 16:2342\u20132350","journal-title":"Eur J Neurosci"},{"key":"3129_CR28","first-page":"4383","volume":"59","author":"ZC Ye","year":"1999","unstructured":"Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383\u20134391","journal-title":"Cancer Res"},{"key":"3129_CR29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm0901-1010","volume":"7","author":"T Takano","year":"2001","unstructured":"Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010\u20131015","journal-title":"Nat Med"},{"key":"3129_CR30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/glia.21113","volume":"59","author":"J Groot de","year":"2011","unstructured":"de Groot J, Sontheimer H (2011) Glutamate and the biology of gliomas. Glia 59:1181\u20131189","journal-title":"Glia"},{"key":"3129_CR31","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1158\/0008-5472.CAN-07-2034","volume":"67","author":"SA Lyons","year":"2007","unstructured":"Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H (2007) Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67:9463\u20139471","journal-title":"Cancer Res"},{"key":"3129_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1460-9568.2009.06804.x","volume":"30","author":"F Beretta","year":"2009","unstructured":"Beretta F, Bassani S, Binda E, Verpelli C, Bello L, Galli R, Passafaro M (2009) The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3\/6-dependent activation in glioma cells. Eur J Neurosci 30:25\u201334","journal-title":"Eur J Neurosci"},{"key":"3129_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-008-9552-2","volume":"88","author":"JF Groot de","year":"2008","unstructured":"de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK (2008) Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. J Neurooncol 88:121\u2013133","journal-title":"J Neurooncol"},{"key":"3129_CR34","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1523\/JNEUROSCI.2180-07.2007","volume":"27","author":"S Ishiuchi","year":"2007","unstructured":"Ishiuchi S, Yoshida Y, Sugawara K, Aihara M, Ohtani T, Watanabe T, Saito N, Tsuzuki K, Okado H, Miwa A, Nakazato Y, Ozawa S (2007) Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci 27:7987\u20138001","journal-title":"J Neurosci"},{"key":"3129_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12253-009-9223-4","volume":"16","author":"DP Schunemann","year":"2010","unstructured":"Schunemann DP, Grivicich I, Regner A, Leal LF, de Ara\u00fajo DR, Jotz GP, Fedrigo CA, Simon D, da Rocha AB (2010) Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line. Pathol Oncol Res 16:285\u2013293","journal-title":"Pathol Oncol Res"},{"key":"3129_CR36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1015-9584(09)60102-0","volume":"29","author":"JM Abdullah","year":"2006","unstructured":"Abdullah JM, Farizan A, Asmarina K, Zainuddin N, Ghazali MM, Jaafar H, Isa MN, Naing NN (2006) Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia. Asian J Surg 29:274\u2013282","journal-title":"Asian J Surg"},{"key":"3129_CR37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7150\/ijbs.6426","volume":"9","author":"SS Willard","year":"2013","unstructured":"Willard SS, Koochekpour S (2013) Glutamate, glutamate receptors, and downstream signaling pathways. Int J Biol Sci 9:948\u2013959","journal-title":"Int J Biol Sci"},{"key":"3129_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2006.09.077","volume":"350","author":"D Koul","year":"2006","unstructured":"Koul D, Takada Y, Shen R, Aggarwal BB, Yung WK (2006) PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochem Biophys Res Commun 350:463\u2013471","journal-title":"Biochem Biophys Res Commun"},{"key":"3129_CR39","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1073\/pnas.091113598","volume":"98","author":"W Rzeski","year":"2001","unstructured":"Rzeski W, Turski L, Ikonomidou C (2001) Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98:6372\u20136377","journal-title":"Proc Natl Acad Sci USA"},{"key":"3129_CR40","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1073\/pnas.0507679102","volume":"102","author":"A Stepulak","year":"2005","unstructured":"Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE, Bittigau P, Felderhoff-Mueser U, Kaindl AM, B\u00fchrer C, Hansen HH, Stryjecka-Zimmer M, Turski L, Ikonomidou C (2005) NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 102:15605\u201315610","journal-title":"Proc Natl Acad Sci USA"},{"key":"3129_CR41","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.24957","volume":"116","author":"FM Iwamoto","year":"2010","unstructured":"Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA (2010) Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas. Cancer 116:1776\u20131782","journal-title":"Cancer"},{"key":"3129_CR42","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2008.21.6895","volume":"27","author":"SA Grossman","year":"2009","unstructured":"Grossman SA, Ye X, Chamberlain M, Mikkelsen T, Batchelor T, Desideri S, Piantadosi S, Fisher J, Fine HA (2009) Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. J Clin Oncol 27:4155\u20134161","journal-title":"J Clin Oncol"},{"key":"3129_CR43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0165-6147(00)01642-4","volume":"22","author":"TM Skerry","year":"2001","unstructured":"Skerry TM, Genever PG (2001) Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 22:174\u2013181","journal-title":"Trends Pharmacol Sci"},{"key":"3129_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1033.2003.03907.x","volume":"271","author":"E Hinoi","year":"2004","unstructured":"Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y (2004) Glutamate signaling in peripheral tissues. Eur J Biochem 271:1\u201313","journal-title":"Eur J Biochem"},{"key":"3129_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-009-0613-1","volume":"132","author":"A Stepulak","year":"2009","unstructured":"Stepulak A, Luksch H, Gebhardt C, Uckermann O, Marzahn J, Sifringer M, Rzeski W, Staufner C, Brocke KS, Turski L, Ikonomidou C (2009) Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 132:435\u2013445","journal-title":"Histochem Cell Biol"},{"key":"3129_CR46","first-page":"565","volume":"31","author":"A Stepulak","year":"2011","unstructured":"Stepulak A, Luksch H, Uckermann O, Sifringer M, Rzeski W, Polberg K, Kupisz K, Klatka J, Kielbus M, Grabarska A, Marzahn J, Turski L, Ikonomidou C (2011) Glutamate receptors in laryngeal cancer cells. Anticancer Res 31:565\u2013573","journal-title":"Anticancer Res"},{"key":"3129_CR47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbrc.2007.12.167","volume":"367","author":"K Watanabe","year":"2008","unstructured":"Watanabe K, Kanno T, Oshima T, Miwa H, Tashiro C, Nishizaki T (2008) The NMDA receptor NR2A subunit regulates proliferation of MKN45 human gastric cancer cells. Biochem Biophys Res Commun 367:487\u2013490","journal-title":"Biochem Biophys Res Commun"},{"key":"3129_CR48","first-page":"3923","volume":"24","author":"N Kalariti","year":"2004","unstructured":"Kalariti N, Lembessis P, Koutsilieris M (2004) Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells. Anticancer Res 24:3923\u20133929","journal-title":"Anticancer Res"},{"key":"3129_CR49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00232-005-0777-0","volume":"205","author":"M Abdul","year":"2005","unstructured":"Abdul M, Hoosein N (2005) N-methyl-D-aspartate receptor in human prostate cancer. J Membr Biol 205:125\u2013128","journal-title":"J Membr Biol"},{"key":"3129_CR50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10549-009-0556-1","volume":"122","author":"WG North","year":"2010","unstructured":"North WG, Gao G, Memoli VA, Pang RH, Lynch L (2010) Breast cancer expresses functional NMDA receptors. Breast Cancer Res Treat 122:307\u2013314","journal-title":"Breast Cancer Res Treat"},{"key":"3129_CR51","first-page":"31","volume":"2","author":"WG North","year":"2010","unstructured":"North WG, Gao G, Jensen A, Memoli VA, Du J (2010) NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment. Clin Pharmacol 2:31\u201340","journal-title":"Clin Pharmacol"},{"key":"3129_CR52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/exd.12048","volume":"21","author":"Z Song","year":"2012","unstructured":"Song Z, He CD, Liu J, Sun C, Lu P, Li L, Gao L, Zhang Y, Xu Y, Shan L, Liu Y, Zou W, Zhang Y, Gao H, Gao W (2012) Blocking glutamate-mediated signalling inhibits human melanoma growth and migration. Exp Dermatol 21:926\u2013931","journal-title":"Exp Dermatol"},{"key":"3129_CR53","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2407-13-468","volume":"13","author":"F Yamaguchi","year":"2013","unstructured":"Yamaguchi F, Hirata Y, Akram H, Kamitori K, Dong Y, Sui L, Tokuda M (2013) FOXO\/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. BMC Cancer 13:468","journal-title":"BMC Cancer"},{"key":"3129_CR54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1600-0714.2004.00226.x","volume":"33","author":"SW Choi","year":"2004","unstructured":"Choi SW, Park SY, Hong SP, Pai H, Choi JY, Kim SG (2004) The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma. J Oral Pathol Med 33:533\u2013537","journal-title":"J Oral Pathol Med"},{"key":"3129_CR55","first-page":"3181","volume":"31","author":"H Luksch","year":"2011","unstructured":"Luksch H, Uckermann O, Stepulak A, Hendruschk S, Marzahn J, Bastian S, Staufner C, Temme A, Ikonomidou C (2011) Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res 31:3181\u20133192","journal-title":"Anticancer Res"},{"key":"3129_CR56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yexcr.2013.11.002","volume":"321","author":"MP Ribeiro","year":"2014","unstructured":"Ribeiro MP, Nunes-Correia I, Santos AE, Cust\u00f3dio JB (2014) The combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells. Exp Cell Res 321:288\u2013296","journal-title":"Exp Cell Res"},{"key":"3129_CR57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/A:1021060610958","volume":"24","author":"A Celli","year":"1999","unstructured":"Celli A, Treves C, Nassi P, Stio M (1999) Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells. Neurochem Res 24:691\u2013698","journal-title":"Neurochem Res"},{"key":"3129_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1083\/jcb.110.1.43","volume":"110","author":"PW Marks","year":"1990","unstructured":"Marks PW, Maxfield FR (1990) Transient increases in cytosolic free calcium appear to be required for the migration of adherent human neutrophils. J Cell Biol 110:43\u201352","journal-title":"J Cell Biol"},{"key":"3129_CR59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/377075a0","volume":"377","author":"MA Lawson","year":"1995","unstructured":"Lawson MA, Maxfield FR (1995) Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 377:75\u201379","journal-title":"Nature"},{"key":"3129_CR60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1113\/jphysiol.1995.sp020738","volume":"485","author":"N Burnashev","year":"1995","unstructured":"Burnashev N, Zhou Z, Neher E, Sakmann B (1995) Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol 485:403\u2013418","journal-title":"J Physiol"},{"key":"3129_CR61","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4161\/cbt.6.12.4965","volume":"6","author":"A Stepulak","year":"2007","unstructured":"Stepulak A, Sifringer M, Rzeski W, Brocke K, Gratopp A, Pohl EE, Turski L, Ikonomidou C (2007) AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth. Cancer Biol Ther 6:1908\u20131915","journal-title":"Cancer Biol Ther"},{"issue":"Suppl","key":"3129_CR62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nn936","volume":"5","author":"JA Kemp","year":"2002","unstructured":"Kemp JA, McKernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5(Suppl):1039\u20131042","journal-title":"Nat Neurosci"},{"key":"3129_CR63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-2236(02)00040-1","volume":"26","author":"GE Hardingham","year":"2003","unstructured":"Hardingham GE, Bading H (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci 26:81\u201389","journal-title":"Trends Neurosci"},{"key":"3129_CR64","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1210\/en.2004-0959","volume":"145","author":"M Fu","year":"2004","unstructured":"Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Minireview: cyclin D1: normal and abnormal functions. Endocrinology 145:5439\u20135447","journal-title":"Endocrinology"},{"key":"3129_CR65","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.25898","volume":"129","author":"A Herner","year":"2011","unstructured":"Herner A, Sauliunaite D, Michalski CW, Erkan M, De Oliveira T, Abiatari I, Kong B, Esposito I, Friess H, Kleeff J (2011) Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Int J Cancer 129:2349\u20132359","journal-title":"Int J Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3129-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3129-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3129-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3129-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T05:31:26Z","timestamp":1718775086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3129-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3129-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]}}}